qHTS: automate the evidence, then measure the workflow
The NIH titration-screening example shows why a richer experiment can matter more than a throughput ranking.
ClarusBIOTECH REVIEWRead, listen & keep
Narration has not been recorded for this article’s current text. The written article is available to download.
Revised September 30, 2026 · Historical case analysis

Dates, outcomes, and decision boundaries
| Measure | Reported result | Context & source |
|---|---|---|
| Publication | 2006 | NIH quantitative screening example [1] |
| Library scale | More than 60,000 compounds | Pyruvate-kinase experiment [1] |
| Titration design | 7 or more concentrations | Concentration–response information [1] |
| Plate format | 1,536 wells | Workflow-specific experimental format [1] |
The study does not supply a current instrument price or a demonstrated return on investment for an LNP laboratory. The suggested metrics require a representative workflow test.
The 2006 NIH quantitative high-throughput screening study provides a laboratory-automation example with a defined scientific output. Inglese and colleagues tested a titration-based screen using pyruvate kinase. The method generated concentration–response information for more than 60,000 compounds rather than treating each compound as a single-point measurement. [1]
Start with the information required
The workflow used seven or more concentrations and a 1,536-well format. Its purpose was to characterize biological activity, potency, and response patterns across the library. The authors' comparison with a single-concentration screen identified an important false-negative problem. The benefit therefore concerned the information returned by the experimental design, not just the number of plates handled. [1]
Measure usable output instead of machine motion
A procurement scorecard should define what constitutes an acceptable concentration–response result, how controls behave, and which failures require repetition. Plate throughput alone can rise while interpretable output falls. For an EV or LNP development laboratory, the corresponding output might be a reproducible characterization record; that is a different workflow and needs its own demonstration.
Put integration burden into the cost model
Include sample preparation, compound or reagent management, calibration, data processing, service, staff intervention, and reruns. A robot that moves material rapidly may still move the bottleneck into assay interpretation or data reconciliation. The original scientific paper does not provide a turnkey procurement budget for a modern configured workstation.
Make the investment decision falsifiable
Ask a supplier to demonstrate the intended workflow with representative samples and predefined acceptance criteria. Compare cost per accepted result, operator intervention, and recovery from a failed run. The qHTS example illustrates a successful research workflow, while the transfer to another laboratory remains a validation task. Vendor rankings should follow that task definition rather than substitute for it.
Source adaptation: the stored automation scorecard inspired the procurement lens. This public NIH case replaces time-sensitive vendor rankings with a specific assay-design example.
What to measure for the next decision
| Dimension | KPI to collect | Decision use |
|---|---|---|
| Quality-adjusted throughput | Accepted response curves per run | Use predefined assay and control criteria. |
| Reliability | Interventions and reruns per accepted result | Count recovery effort rather than ignoring failed runs. |
| Operating cost | Fully configured cost per accepted result | Include service, consumables, and interpretation. |
THE NEXT VALUE INFLECTION
What would change the decision
Ask a supplier to demonstrate the intended workflow with representative samples and predefined acceptance criteria. Compare cost per accepted result, operator intervention, and recovery from a failed run. The qHTS example illustrates a successful research workflow, while the transfer to another laboratory remains a validation task. Vendor rankings should follow that task definition rather than substitute for it.
Editorial record
Prepared by Clarus Biotech Review editorial team. Updated 10/1/2026.
Publication relationship: ClarusReview is connected to BioClarus Consulting. No article-specific sponsorship is recorded.
Report a correctionDiscuss this paper
Share evidence, ask a question, or offer a professional perspective. Community guidelines
Loading discussion…